Europe needs to incentivise OTC innovation

29 May 2017 - Deborah Wilkes

Archived

One of the biggest challenges facing innovators in the self-care industry in Europe is the lack of intellectual property rights, says Birgit Schuhbauer, president of the Association of the European Self-Medication Industry (AESGP).

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: